← ANALYST RATINGS · TIPRANKS

Pro-Dex (PDEX): analyst forecast and price target

$58.26 −2.93% close 16.10.26 · market cap $193M · Healthcare · Medical - Instruments & Supplies IWM 0.01%
Price targets and ratings of

Analyst consensus

Moderate Buy

1 Buy0 Hold0 Sell

Ratings of 1 analysts in the last 3 months

12-month forecast

$74.00+27.0% upside

Based on 1 price targets given in the last 3 months, the average target is $74.00, the highest $74.00, the lowest $74.00. The average is +27.0% from the last price of $58.26.

$40.00$60.00Jan 26AprJulOctJan 27AprJulOctHigh$74.00Average$74.00Low$74.00
Highest target $74.00 Average target $74.00 Lowest target $74.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Edward Woo★★★★★★★★★★#12401 · hits 30% · avg −17.6% Ascendiant $74.00 Buy +27.0% Reiterated 10.09.26on TipRanks Sep 22 02:15 −0.8%next day +4.1% · 5 days +15.5%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Pro-Dex

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Edward Woo★★★★★★★★★★Ascendiant · #12401
Hits 30%146 of 490 Average return −17.6%
1 year Edward Woo★★★★★★★★★★Ascendiant · #12401
Hits 30%146 of 490 Average return −17.6%
2 years Edward Woo★★★★★★★★★★Ascendiant · #12401
Hits 30%146 of 490 Average return −17.6%

Most profitable

3 months Edward Woo★★★★★★★★★★Ascendiant · #12401
Hits 30%146 of 490 Average return −17.6%
1 year Edward Woo★★★★★★★★★★Ascendiant · #12401
Hits 30%146 of 490 Average return −17.6%
2 years Edward Woo★★★★★★★★★★Ascendiant · #12401
Hits 30%146 of 490 Average return −17.6%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $74.00 at a price of $69.00 (+7.2%); now: $74.00 at $58.26 (+27.0%).

$60.00$65.00$70.00Sep 15Oct 1Oct 15Average target$74.00Price$58.26

PriceAverage targetTop analysts’ target

Recommendation trend

00001Oct 25NovDecJan 26FebMarApr1May1Jun1JulAug1Sep1Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy111011
Hold000000
Sell000000

Earnings and sales forecast

Next report: 29.10.26 (Q1 2027, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.67 (from $0.67 to $0.67). Last quarter: $0.87.

Sales

Next quarter’s sales estimate — $20M (from $20M to $20M). Last quarter: $20M.

Best top-analyst consensus in the sector · Healthcare

OVIDOvid Therapeutics
AXGNAxoGen
PTGXProtagonist TherapeuticsStrong Buy
ESTAEstablishment Labs HoldingsStrong Buy
REPLReplimune GroupStrong Buy
About Pro-Dex
  • CEO: Richard Lee Van Kirk Jr.
  • Employees: 204
  • 2361 McGaw Avenue, Irvine, CA, 92614, US
  • www.pro-dex.com

Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.

Data from the stock’s TipRanks forecast page, read 434 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗